Figure 3.

First, second, third, and fourth columns show images of CNVM treated with anti-VEGF at baseline, fourth, sixth, and seventh month, respectively. Anti-VEGF given at baseline till fourth month (1 injection/month) and repeated at sixth month. (a and b) OCTA at the choroidal level shows classic branching network (arrow) decreasing in size from baseline to 1 month. (e–h) Microperimetry (MP3) shows increasing and decreasing retinal sensitivity corresponding to the network size on OCTA. (c and d) A new neovascular network (double-headed arrow) near the regressing old network. (i–l) Overlay of OCTA on MP3